Ieq Capital LLC acquired a new position in Xeris Pharmaceuticals, Inc. (NASDAQ:XERS – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 50,169 shares of the company’s stock, valued at approximately $147,000. Ieq Capital LLC owned about 0.08% of Xeris Pharmaceuticals as […]
Squarepoint Ops LLC lowered its holdings in Xeris Pharmaceuticals, Inc. (NASDAQ:XERS – Get Rating) by 61.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,595 shares of the company’s stock after selling 20,008 shares during the period. Squarepoint […]
Veery Capital LLC purchased a new position in Xeris Pharmaceuticals, Inc. (NASDAQ:XERS – Get Rating) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 12,544 shares of the company’s stock, valued at approximately $37,000. Other hedge funds and other institutional […]